In line with Practice 6.1 of the Malaysian Code on Corporate Governance (“MCCG”) issued by the Securities Commission Malaysia on 28 April 2021, the Board has via its Nomination and Remuneration Committee undertaken a formal evaluation to determine each individual Director eligibility to stand for re-election at the 46th AGM of the Company which include the following: (i) self and peer performance evaluation, such as priorities context of issues in line with corporate objective, provide realism and practical advice, and add value to Board meetings; (ii) Independent Non-Executive Director self-evaluation such as length of service, independent of management and judgement and fulfill the criteria of independences; and (iii) level of independence demonstrated by the Independent Non-Executive Director, and his/her ability to act in the best interest of the Company in decision-making by providing an annual declaration of independence. Based on the evaluation results above, all individual Directors (including the retiring Directors) have fulfilled the performance evaluation required. In addition, all Independent Non-Executive Directors have provided their annual declaration of independence. Hence, the Board approved the Nomination and Remuneration Committee’s recommendation that Datuk Mark Victor Rozario and Ms Emelia Binti Matrahah who retire in accordance with Clause 112 of the Company’s Constitution and Tan Sri Dato’ Sri Mohamad Fuzi Bin Harun, Ms Alice Dora Boucher and Mr Jared Ang Tzer Shen who retire by rotation in accordance with Clause 113 of the Company’s Constitution are eligible to stand for re-election. Ms Alice Dora Boucher is the member of the Nomination and Remuneration Committee (“NRC”) has abstained from deliberations and decisions on her own eligibility at the NRC and Board meetings. Whereas, Tan Sri Dato' Sri Mohamad Fuzi Bin Harun, Datuk Mark Victor Rozario, Ms Emelia Binti Matrahah and Mr Jared Ang Tzer Shen had abstained from deliberations and decisions on their own eligibility at the Board Meeting. In line with Bursa Securities announcement on 19 January 2022, Paragraph 15.01A of Bursa Securities Main Market Listing Requirements, and Fit and Proper Policy adopted by the Board during the year 2022, the Directors who eligible for re-election have completed their respective Fit & Proper Policy Compliance Checklist to declare that they are a fit and proper person to act as a Director of the Company. EXPLANATORY NOTES TO SPECIAL BUSINESS 1. Ordinary Resolution 9 - Proposed authority for Directors to allot and issue shares pursuant to Sections 75 and 76 of the Act and waiver of pre-emptive rights The general mandate sought by the Company under the proposed Ordinary Resolution 9 is to renew the previous general mandate granted to the Directors of the Company at the Forty-Fifth Annual General Meeting of the Company held on 24 June 2024 to allot and issue shares pursuant to Sections 75 and 76 of the Act. As at the date of this Notice of Meeting, no new shares in the Company were issued under the previous general mandate, which will lapse at the conclusion of the 46th AGM of the Company and hence, no proceeds raised therefrom. The proposed Ordinary Resolution 9, if passed, will empower the Directors of the Company to issue and allot not more than ten per centum (10%) of the Company’s total number of issued shares (excluding treasury shares) for the time being speedily without having to convene a general meeting. This authority, unless revoked or varied by the Company in a general meeting, will expire at the conclusion of the Forty-Seventh Annual General Meeting (“47th AGM”) of the Company. The proposed Ordinary Resolution, if passed, will exclude shareholders’ pre-emptive rights to be offered such new shares to be issued by the Company pursuant to this resolution. Instances for which the Company may issue new shares under this general mandate include but are not limited to the purpose(s) of complying with public shareholding spread requirements and raising funds through private placement for purposes of working capital requirement and/or allowing the entry of strategic partners. FINANCIAL STATEMENTS & OTHER INFORMATION 377
RkJQdWJsaXNoZXIy NDgzMzc=